No Data
Shanghai Medicilon Inc. (688202.SH): Recently, the prices of laboratory monkeys have stabilized.
On December 20, Gelonghui reported that Shanghai Medicilon Inc. (688202.SH) recently stated during an institutional investor research session that the prices of experimental monkeys have stabilized. The company has proactively taken various measures to ensure the stability of its supply of experimental animals, particularly experimental monkeys, by enriching procurement channels and deepening cooperation with suppliers of experimental animals, to meet the needs of its operation.
Shanghai Medicilon Inc. (688202.SH): The company has established a multi-point layout in key overseas industrial regions such as the USA, Europe, and the Asia-Pacific.
Gelonghui, December 20, Shanghai Medicilon Inc. (688202.SH) recently stated during an institutional investor survey that the company is establishing a multi-point layout in major overseas industry core regions such as the USA, Europe, and the Asia-Pacific, strengthening laboratory capabilities and building a business team. Currently, the company has over ten members in its BD team in the USA and will continue to enhance the BD team in the European market, increase communication between overseas BD and domestic research teams, establish a client information intelligence system, ensure effective management of major client services, and gradually build a market sales system that adapts to overseas market competition. In addition, the company will actively participate in overseas industry conferences, increasing the regular engagement of the research team.
Further Weakness as Shanghai Medicilon (SHSE:688202) Drops 8.2% This Week, Taking Three-year Losses to 85%
Is Shanghai Medicilon (SHSE:688202) Weighed On By Its Debt Load?
Medici: Medici: THIRD QUARTER REPORT 2024
Medici: Third quarter report 2024
Is Shanghai Medicilon (SHSE:688202) Using Too Much Debt?
No Data
